Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 May 21:14:447.
doi: 10.3389/fnins.2020.00447. eCollection 2020.

Cochlear Implantation Outcomes in Patients With OTOF Mutations

Affiliations
Review

Cochlear Implantation Outcomes in Patients With OTOF Mutations

Dandan Zheng et al. Front Neurosci. .

Abstract

Auditory neuropathy is a special type of hearing loss caused by dysfunction of the synapse of the inner hair cells, the auditory nerve, and/or the auditory nerve itself. For patients with auditory neuropathy who have severe to profound hearing loss or failed auditory skills development with hearing-aids, cochlear implantation (CI) serves as the only possible effective treatment. It is accepted that the exact sites of lesion causing auditory neuropathy determine the CI performance. Mutations in the OTOF gene were the first identified and the most common cause of congenital auditory neuropathy. The site of lesion in patients with auditory neuropathy caused by biallelic OTOF mutations (OTOF-related auditory neuropathy) is presumed to be presynaptic, leaving auditory nerve function intact. Thus, OTOF-related auditory neuropathy is expected to have good CI performances. In this review, we describe the CI outcomes in patients with OTOF mutations. We will focus on whether biallelic OTOF mutations are ideal indications for CI in patients with auditory neuropathy. Also, the factors that may still influence the CI outcomes in patients with OTOF mutations are discussed.

Keywords: OTOF; auditory neuropathy; cochlear implantation; outcomes; rehabilitation.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
PRISMA flow diagram.

References

    1. Berlin C. I., Hood L. J., Morlet T., Wilensky D., Li L., Mattingly K. R., et al. (2010). Multi-site diagnosis and management of 260 patients with auditory neuropathy/dys-synchrony (auditory neuropathy spectrum disorder). Int. J. Audiol. 49 30–43. 10.3109/14992020903160892 - DOI - PubMed
    1. Black J., Hickson L., Black B., Perry C. (2011). Prognostic indicators in paediatric cochlear implant surgery: a systematic literature review. Cochlear. Implants Int. 12 67–93. 10.1179/146701010X486417 - DOI - PubMed
    1. Cardon G., Sharma A. (2013). Central auditory maturation and behavioral outcome in children with auditory neuropathy spectrum disorder who use cochlear implants. Int. J. Audiol. 52 577–586. 10.3109/14992027.2013.799786 - DOI - PMC - PubMed
    1. Chen K., Liu M., Wu X., Zong L., Jiang H. (2018). Targeted next generation sequencing reveals OTOF mutations in auditory neuropathy spectrum disorder. Int. J. Pediatr. Otorhinolaryngol. 115 19–23. 10.1016/j.ijporl.2018.09.008 - DOI - PubMed
    1. Chiu Y. H., Wu C. C., Lu Y. C., Chen P. J., Lee W. Y., Liu A. Y., et al. (2010). Mutations in the OTOF gene in Taiwanese patients with auditory neuropathy. Audiol. Neurootol. 15 364–374. 10.1159/000293992 - DOI - PubMed

LinkOut - more resources